BRAINSTORM CELL THERAPEUTICS INC. (19)

Browse by Contract Category

Contracts

Separation Agreement, effective January 20, 2023, between Brainstorm Cell Therapeutics Inc. and Dr. Ralph Kern (Filed With SEC on January 4, 2023)
Amendment No. 3 to Offer Letter Agreement, dated January 3, 2023, between Brainstorm Cell Therapeutics Inc. and Dr. Stacy Lindborg (Filed With SEC on January 4, 2023)
Amended and Restated Distribution Agreement, dated September 25, 2020, by and among Brainstorm Cell Therapeutics Inc., SVB Leerink LLC and Raymond James & Associates, Inc (Filed With SEC on September 25, 2020)
Securities Purchase Agreement, dated March 6, 2020, by and between Brainstorm Cell Therapeutics Inc. and AI Fund 1 LLC (Filed With SEC on March 6, 2020)
Amendment No. 2 to Offer Letter Agreement dated September 18, 2022 between Brainstorm Cell Therapeutics Inc. and Dr. Stacy Lindborg (Filed With SEC on September 22, 2022)
Brainstorm Cell Therapeutics Inc. Fourth Amendment to the Second Amended and Restated Director Compensation Plan (Filed With SEC on March 28, 2022)
Brainstorm Cell Therapeutics Inc. Fourth Amendment to the Second Amended and Restated Director Compensation Plan (Filed With SEC on November 15, 2021)
Offer letter, dated May 26, 2020, by and between Brainstorm Cell Therapeutics Inc. and Stacey Lindborg (Filed With SEC on February 4, 2021)
Offer Letter by and between Brainstorm Cell Therapeutics Inc. and Anthony Waclawski (Filed With SEC on September 3, 2020)
Amendment to Uri Yablonka Employment Agreement (Filed With SEC on August 5, 2020)
Amendment to Chaim Lebovits Employment Agreement (Filed With SEC on August 5, 2020)
Employment Agreement by and between Brainstorm Cell Therapeutics Inc. and David Setboun (Filed With SEC on April 3, 2020)
Distribution Agreement, dated March 6, 2020, by and between Brainstorm Cell Therapeutics Inc. and Raymond James & Associates, Inc (Filed With SEC on March 6, 2020)
Common Stock Purchase Warrant for the purchase of Common Stock, issued March 6, 2020 by Brainstorm Cell Therapeutics Inc. to Abbhi Investments, LLC (Filed With SEC on March 6, 2020)
Offer letter, dated September 5, 2019, by and between Brainstorm Cell Therapeutics Inc. and Preetam Shah (Filed With SEC on November 14, 2019)
Warrant Exercise Agreement (Filed With SEC on August 2, 2019)
Form of Warrant (Filed With SEC on August 2, 2019)
Distribution Agreement, dated June 11, 2019, by and between Brainstorm Cell Therapeutics Inc. and Raymond James & Associates, Inc (Filed With SEC on June 11, 2019)
Employment Agreement by and between Brainstorm Cell Therapeutics Inc. and Arturo Araya effective August 28, 2018 (Filed With SEC on March 29, 2019)